Chutian Technology (300358.SZ): ROMACO's revenue is expected to grow in 2024, and gross margin is also expected to grow
Gelonghui, May 24 | Chutian Technology (300358.SZ) was surveyed by a specific target on May 24. “What is the cause of ROMACO's low gross profit and net profit?” The company replied that ROMACO's net interest rate remains around 5%, and the scale benefits of the company's scale have not yet been shown. At the same time, the Russian-Ukrainian war affected its supply chain, and gross profit declined. There was a certain difference between ROMACO's gross profit calculation scale and that of the domestic market. ROMACO's revenue is expected to increase in 2024, and gross margin is also expected to increase.
Chutian Technology (300358.SZ): The company provides intelligent overall solutions for global pharmaceutical production customers, involving a wide range of drugs
Gelonghui, May 9丨Chutian Technology (300358.SZ) said on the investor interactive platform that the company provides global pharmaceutical production customers with intelligent overall solutions, involving a wide range of drugs. Insulin cell culture is only one type of drug. It involves fermentation, dosing, centrifugation, ultrafiltration, low-pressure chromatography, high-pressure chromatography, freeze-drying, filling, injection pen assembly, packaging, etc. We can provide equipment and services according to the actual needs of customers. It is part of the company's existing products. The specific data is based on the product sales data announced in the company's regular reports. Investors are requested to pay attention to investment risks and invest rationally.
Chutian Technology (300358.SZ): Reactors and other related equipment and consumables involved in the synthetic biology sector can be provided according to customer needs
Gelonghui, May 9 | Chutian Technology (300358.SZ) said on the investor interactive platform that related equipment and consumables such as reactors, purification systems, liquid dispensing systems, centrifugal separation systems, disposable bags, fillers, etc. involved in the synthetic biology sector can all be provided according to customer needs.
We Think That There Are More Issues For Truking Technology (SZSE:300358) Than Just Sluggish Earnings
Truking Technology Limited's (SZSE:300358) recent weak earnings report didn't cause a big stock movement. Our analysis suggests that along with soft profit numbers, investors should be aware of some
Truking Technology (SZSE:300358) Sheds CN¥437m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But the risk of stock picking is that you will likely buy under-perfor
Chutian Technology (300358.SZ) announced first-quarter results, with a net loss of 208.717 million yuan, a year-on-year profit to loss
Chutian Technology (300358.SZ) released its report for the first quarter of 2024, with revenue of 1,392 billion yuan,...
Chutian Technology (300358.SZ) once again passed the high-tech enterprise certification
Gelonghui, April 9, 丨 Chutian Technology (300358.SZ) announced that the company recently received the “High-tech Enterprise Certificate” jointly issued by the Hunan Provincial Department of Science and Technology, the Hunan Provincial Department of Finance, and the Hunan Provincial Taxation Bureau of the State Administration of Taxation. The company once again passed the certification of a high-tech enterprise. Certificate number GR202343005519; issued on December 8, 2023; valid for three years.
The controlling shareholder of Chutian Technology (300358.SZ) increased its holdings by 657,400 shares
Chutian Technology (300358.SZ) announced that as of March 25, 2024, the planned time to increase holdings is over half...
Chutian Technology (300358.SZ) has established an intelligence research center, which mainly studies optimal algorithms and theories and their applications in machine learning and artificial intelligence
Gelonghui March 20 丨 Chutian Technology (300358.SZ) said on the investor interactive platform that Chutian Technology has set up an intelligent research center to mainly study optimal algorithms and theories and their applications in machine learning and artificial intelligence. It provides a full chain of technical services for the digital transformation needs of pharmaceutical companies such as intelligent manufacturing, intelligent logistics, and intelligent supply. Use operational optimization algorithms and artificial intelligence technology to transform business problems into mathematical models to solve decision optimization problems in a series of business scenarios such as production quality, warehouses, scheduling, and sales, and achieve intelligent decision-making based on data to enable the digital transformation of pharmaceutical companies
Do Its Financials Have Any Role To Play In Driving Truking Technology Limited's (SZSE:300358) Stock Up Recently?
Truking Technology (SZSE:300358) has had a great run on the share market with its stock up by a significant 20% over the last month. Given that stock prices are usually aligned with a company's fina
Truking Technology (SZSE:300358) Takes On Some Risk With Its Use Of Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Chutian Technology (300358.SZ): “Chutian Bonds Transfer” will be listed for trading on February 29
Zhitong Finance App News, Chutian Technology (300358.SZ) announced that the company's 1 billion yuan convertible corporate bond will be listed and traded on the Shenzhen Stock Exchange from February 29, 2024. The bonds are abbreviated as “Chutian Convertible Bonds”, and the bond code is “123240.”
Truking Technology Limited's (SZSE:300358) Shares Not Telling The Full Story
With a price-to-earnings (or "P/E") ratio of 12.2x Truking Technology Limited (SZSE:300358) may be sending very bullish signals at the moment, given that almost half of all companies in China have P/E
Chutian Technology (300358.SZ): Can provide customers with design, purification, water treatment, intelligent storage, etc.
Gelonghui, January 29丨Chutian Technology (300358.SZ) said on the investor interactive platform that in biopharmaceutical-related products, the company can provide customers with overall personalized solutions covering design, purification, separation and purification, distribution, post-testing packaging, intelligent storage, etc., from front to back.
Chutian Technology (300358.SZ): The subsidiary Chutian Pete can provide global customers with solutions related to peptide synthesis
Gelonghui, January 29丨Chutian Technology (300358.SZ) said on the investor interactive platform that the company's subsidiary Chutian Pete can provide customers around the world with solutions related to peptide synthesis, and at the same time, our company can also provide equipment related to synthetic organisms such as reactors. The above equipment and solutions can be customized and produced and sold according to customer needs.
The One-year Earnings Decline Is Not Helping Truking Technology's (SZSE:300358 Share Price, as Stock Falls Another 6.5% in Past Week
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. While individual stocks can be big winners, plenty more fail to generate satisfactory ret
Truking Technology Limited's (SZSE:300358) Stock Price Dropped 6.5% Last Week; Private Companies Would Not Be Happy
Key Insights Significant control over Truking Technology by private companies implies that the general public has more power to influence management and governance-related decisions A total of 3 inv
Chutian Technology (300358.SZ)'s application to issue convertible corporate bonds to unspecified targets was reviewed and approved by the Shenzhen Stock Exchange
According to the Zhitong Finance App, Chutian Technology (300358.SZ) issued an announcement. On November 23, 2023, the Shenzhen Stock Exchange Listing Review Committee held the 85th Listing Review Committee review meeting in 2023 to review the company's application to issue convertible corporate bonds to unspecified targets. According to the review results of the conference, the company's application to issue convertible corporate bonds to an unspecified target met the issuance conditions, listing conditions, and information disclosure requirements. Furthermore, the company's issuance of convertible corporate bonds to an unspecified target is still subject to the registration procedure of the China Securities Regulatory Commission.
Hyde Control (002184.SZ): Major cooperative enterprises in the intelligent pharmaceutical equipment industry include Dongfulong, Chutian Technology, Zhejiang Tailin, and Xinhua Medical
On October 31, Gelonghui, Hyde Control (002184.SZ) stated on the investor interactive platform that the industrial informatization business, one of the company's main businesses, mainly provides safe and reliable automation, information product services, and automation and information technology integration system solutions for users in pharmaceutical and other industries. The company's main partners in the intelligent pharmaceutical equipment industry include Dongfulong, Chutian Technology, Zhejiang Tailin, and Xinhua Medical.
Chutian Technology (300358.SZ) released results for the first three quarters, with net profit of 287 million yuan, a year-on-year decrease of 37.91%
Chutian Technology (300358.SZ) released its report for the third quarter of 2023. The company achieved revenue of 5 in the first three quarters...
No Data